Additionally, we explored the differences observed in MAP3K3 and CCM gene mutation related to clinicopathological features (hemorrhagic episodes, lesion size, and symptoms) between the brainstem and supratentorial CCM lesions. This evidence concerns the gene MAP3K3 and cerebral cavernous malformation.